Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
ABSTRACT: Objective: To determine whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels after the first dose of vaccine can predict the final antibody response, and whether this is dependent on the vaccine type.Methods: Sixty-nine recipients of BNT162b2 (Pfizer/BioNTec...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2021-09-01
|
| Saila: | International Journal of Infectious Diseases |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S1201971221006202 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|